Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKesson
Dow
Merck
Moodys

Last Updated: February 4, 2023

Patent: 10,112,981


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 10,112,981
Title:Methods for treatment of stroke or cerebrovascular accidents using an ET.sub.B receptor agonist
Abstract: Methods of using an ET.sub.B receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ET.sub.B receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident.
Inventor(s): Gulati; Anil (Naperville, IL)
Assignee: MIDWESTERN UNIVERSITY (Downers Grove, IL)
Application Number:15/352,238
Patent Claims:see list of patent claims

Details for Patent 10,112,981

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 06/01/1989 See Plans and Pricing 2027-08-21
Amgen, Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 See Plans and Pricing 2027-08-21
Amgen, Inc. PROCRIT epoetin alfa Injection 103234 See Plans and Pricing 2027-08-21
Genentech, Inc. TNKASE tenecteplase For Injection 103909 06/02/2000 See Plans and Pricing 2027-08-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
AstraZeneca
McKinsey
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.